Viridian Therapeutics, Inc.\DE (VRDN) Selling, General & Administrative (2013 - 2026)
Viridian Therapeutics, Inc.\DE's Selling, General & Administrative came in at $54.98 million for Q2 2026, up 171.9% from $20.22 million a year earlier and up 42.1% from the prior quarter.
Viridian Therapeutics, Inc.\DE (VRDN) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Viridian Therapeutics, Inc.\DE reported Selling, General & Administrative of $151.65 million, up 125.3% year-over-year; for FY2025, it came in at $95.32 million, up 56.0% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 48.4% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $61.08 million in FY2024 (-35.7%), $95 million in FY2023 (+170.0%), $35.18 million in FY2022 (+36.3%) and $25.81 million in FY2021 (+94.5%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2013.
- Year-over-year, Selling, General & Administrative has increased for six consecutive quarters, with growth averaging 54.8% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2023 (growth of 234.8%), and the weakest in Q4 2024 (a decline of 52.8%).
- Business Quant data shows VRDN's Selling, General & Administrative at $38.68 million (Q1 2026), $33.67 million (Q4 2025) and $24.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | 54.98 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.98 Mn |
| Mar 31, 2026 | 38.68 Mn |
| Dec 31, 2025 | 33.67 Mn |
| Sep 30, 2025 | 24.32 Mn |
| Jun 30, 2025 | 20.22 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Dec 31, 2024 | 15.58 Mn |
| Sep 30, 2024 | 14.41 Mn |
| Jun 30, 2024 | 16.07 Mn |
| Mar 31, 2024 | 15.03 Mn |
| Dec 31, 2023 | 32.99 Mn |
| Sep 30, 2023 | 20.91 Mn |
| Jun 30, 2023 | 19.26 Mn |
| Mar 31, 2023 | 21.83 Mn |
| Dec 31, 2022 | 9.85 Mn |
| Sep 30, 2022 | 8.86 Mn |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 8.36 Mn |
| Dec 31, 2021 | 6.90 Mn |
| Sep 30, 2021 | 6.22 Mn |
Viridian Therapeutics, Inc.\DE Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();